Your browser doesn't support javascript.
loading
A promoter polymorphism in human interleukin-32 modulates its expression and influences the risk and the outcome of epithelial cell-derived thyroid carcinoma.
Plantinga, Theo S; Costantini, Irene; Heinhuis, Bas; Huijbers, Angelique; Semango, George; Kusters, Benno; Netea, Mihai G; Hermus, Ad R M M; Smit, Jan W A; Dinarello, Charles A; Joosten, Leo A B; Netea-Maier, Romana T.
Affiliation
  • Plantinga TS; Department of Medicine, Radboud University Nijmegen Medical Centre, Geert Grooteplein 8, Nijmegen, 6525 GA, The Netherlands.
Carcinogenesis ; 34(7): 1529-35, 2013 Jul.
Article in En | MEDLINE | ID: mdl-23486016

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Thyroid Neoplasms / Interleukins / Promoter Regions, Genetic / Epithelial Cells Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Carcinogenesis Year: 2013 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Thyroid Neoplasms / Interleukins / Promoter Regions, Genetic / Epithelial Cells Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Carcinogenesis Year: 2013 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom